Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,632.1 | 78.62 | 3,91,607.46 | 753.53 | 0.98 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,409 | 77.05 | 1,70,148.1 | 667 | 0.47 | 2,536 | 561.08 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,589.2 | 61.1 | 1,21,466 | 551 | 0.17 | 2,567 | 224.34 |
Cipla Ltd CIPLA | 1,499.8 | 23.44 | 1,21,102.1 | 1,303.13 | 1.07 | 4,501.66 | 397.39 |
Mankind Pharma Ltd MANKIND | 2,618.9 | 59.68 | 1,08,009.05 | 412.76 | 0 | 2,541.36 | 354.71 |
Ajanta Pharma reported a strong EBITDA margin of 25% in the quarter.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
